Filter
1473
Filtered Results: 1473
Text search:
Malik,
A.
A.
Featured
Recommendations
107
New Publications
368
Language
Document type
No document type
788
Studies & Reports
365
Guidelines
133
Strategic & Response Plan
60
Manuals
58
Training Material
24
Fact sheets
17
Situation Updates
11
Infographics
7
Brochures
6
Resource Platforms
3
Videos
1
Countries / Regions
Senegal
116
Burkina Faso
113
Mali
110
Guinea
95
Global
75
Africa
66
Congo, Democratic Republic of
63
Sierra Leone
62
Côte d’Ivoire / Ivory Coast
61
Liberia
61
Niger
45
Indonesia
41
Benin
36
India
33
Cameroon
32
West and Central Africa
31
Ethiopia
31
Nigeria
30
Kenya
27
Ghana
27
Chad
27
Rwanda
22
Uganda
21
Tanzania
18
Mozambique
17
Germany
15
East and Southern Africa
15
South Africa
15
Zambia
15
Syria
14
Haiti
14
Central African Republic
14
Togo
13
Malawi
13
Middle East and North Africa
13
South Sudan
13
Yemen
12
Madagascar
12
Zimbabwe
11
Bangladesh
11
Brazil
11
Somalia
11
Afghanistan
10
Asia
9
Latin America and the Carribbean
9
Nepal
8
Russia
8
Sudan
8
Ukraine
7
Congo-Brazzaville
7
Philippines
7
Cambodia
7
Guinea-Bissau
7
France
7
Libya
7
Pakistan
7
Colombia
6
Burundi
6
Western and Central Europe
6
Myanmar / Burma
6
Jordan
5
Eastern Europe
5
Botswana
5
Gambia
4
Mauritania
4
South–East Asia Region
4
Tunisia
4
Lebanon
4
Namibia
4
Egypt
4
Angola
4
Iraq
4
Thailand
3
Lesotho
3
China
3
Canada
3
Peru
3
Morocco
3
Eastern Europe and Central Asia
3
Luxembourg
3
Belgium
3
Djibouti
3
Timor Leste/ East Timor
2
Turkey
2
Italy
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Algeria
2
Palestine
2
Eswatini/ Swaziland
2
Tajikistan
1
Switzerland
1
Mexico
1
Kazakhstan
1
Laos
1
Qatar
1
Armenia
1
USA
1
Dominican Republic
1
Venezuela
1
Mauritius
1
Spain
1
Israel
1
Bolivia
1
Papua New Guinea
1
Moldova
1
Sri Lanka
1
Romania
1
Greece
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
444
Women & Child Health
109
Clinical Guidelines
108
Public Health
93
Key Resources
68
Capacity Building
19
Pharmacy & Technologies
13
Toolboxes
Ebola
161
COVID-19
129
Mental Health
115
Planetary Health
70
HIV
67
Refugee
62
Disability
61
Rapid Response
47
NTDs
46
Conflict
40
Caregiver
38
Global Health Education
34
AMR
32
TB
30
Pharmacy
18
NCDs
17
Health Financing Toolbox
15
Natural Hazards
12
Cholera
10
Polio
7
Specific Hazards
5
Social Ethics
5
Zika
4
Typhoon
1
Every year, an estimated 15 million babies are born preterm – before 37 weeks of pregnancy. That is more than 1 in 10 live births. Approximately 1 million children die each year worldwide due to complications from their early birth. Those that survive often face a lifetime of ill-health including ...
The National AIDS Control Council recognizes the growing, organized and progressive inter-faith religious voice in the spheres of governance and development in Kenya. Across the country, the Faith Sector has been involved in HIV prevention, treatment, care and support to programmes towards...
Modelling the health impacts of disruptions to essential health services during COVID-19 Module 1
Several epidemiological models have been created to assess the potential impact of disruptions to essential health services caused by COVID-19 on morbidity and mortality from conditions other than COVI...
Ghana's attempt to regulate health care waste management started in 2002 with the development of guidelines on health care waste manage-ment by the Environmental Protection Agency (EPA). In 2006, the Ministry of Health developed the health care waste policy and guidelines. This guidance document im...
Medicina 2019, 55, 553; doi:10.3390/medicina55090553
Results: Twenty-one studies were analyzed, most of them demonstrating an association between the existence of burnout and the worsening of patient safety. High levels of burnout is more common among physicians and nurses, and it is associated wit...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Onchocerciasis used to be an important public health problem in Africa, with over 37 million people infected and millions suffering from debilitating skin disease, terrible itching, impaired vision and
blindness. But the epidemiological situation has improved dramatically over the last two decades....
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas of economically dis...
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long
been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still
kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas
of economically ...
La schistosomiase humaine est une maladie parasitaire chronique et aigüe causée par une infection par des douves du sang (vers trématodes) du genre Schistosoma. Cette maladie est un problème de santé publique dans les zones tropicales et
subtropicales d’Afrique, d’Asie, des Caraïbes et d...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
This report is the annual global monitoring report documenting progress towards Sustainable Development Goal (SDG) 2 targets 2.1 and 2.2. This year’s report explores the links between urbanization and changing food systems and how these changes are impacting the availability, affordability and des...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...
The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are allocated and spent, this is determined by the PFM r...
It is widely understood that the food insecurity crisis in the Sahel and the Horn of Africa is one of the world’s fastest growing and most neglected crises. It lacks sufficient global focus, resources and urgency. As in so many crises, women and girls are disproportionately affected and shoulder t...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
